Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) insider Catriona Yale sold 597 shares of the firm’s stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $20.76, for a total value of $12,393.72. Following the sale, the insider now owns 77,910 shares of the company’s stock, valued […]
Commodore Capital LP boosted its holdings in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 112.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,675,000 shares of the company’s stock after acquiring an additional 885,000 shares during the quarter. Akero Therapeutics accounts […]
Swiss National Bank boosted its stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 46.8% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 96,300 shares of the company’s stock after buying an additional 30,700 shares during the period. Swiss National Bank’s holdings in Akero Therapeutics were worth $4,496,000 at the end […]
Akero Therapeutics (NASDAQ:AKRO – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.71) earnings per share for the quarter, missing the consensus estimate of ($0.70) by ($0.01), MarketWatch Earnings reports. Akero Therapeutics Trading Up 5.0 % Akero Therapeutics stock opened at $14.91 on Wednesday. The company has a debt-to-equity ratio […]
Akero Therapeutics (NASDAQ:AKRO – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.71) earnings per share for the quarter, missing the consensus estimate of ($0.70) by ($0.01), MarketWatch Earnings reports. Akero Therapeutics Stock Performance AKRO stock opened at $14.91 on Wednesday. The firm has a market cap of $829.00 million, […]